txpm pharmacy tirzepatide Tirzepatide Injection | Starts at
Description
The dual action gives better glucose control and significant weight loss compared to older GLP-1 agonists alone
Book your consultation today
The patch is designed for gentle, comfortable use
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.
Nausea after eating is a common side effect of semaglutide and other GLP-1 medications, affecting up to 40% of users in clinical trials
